Şalazyon Tedavisinde Triamsinolon Asetonid Enjeksiyonunun Etkinliği

Öz

Amaç: Şalazyon tedavisinde lezyon içine yapılan triamsinolon asetonid enjeksiyonunun etkinliğini ve güvenilirliğini değerlendirmek. Gereç ve Yöntemler: En az bir ay süren konservatif ve medikal tedaviye yanıt vermeyen orta (3-7 mm) ve büyük boyutlarda (>7 mm) primer şalazyonu olan 20 göz retrospektif olarak incelendi. Lezyonların içine 0.1-0.2 mL triamsinolon asetonid (40 mg/mL) enjekte edilerek, enjeksiyondan önce ve enjeksiyondan sonraki ikinci hafta, birinci ay, ikinci ay, üçüncü ay lezyon boyutları ve komplikasyonlar kaydedildi. Bulgular: Enjeksiyon sonrası ikinci hafta kontrollerinde 17 (%85) hastada lezyon boyutunda gerileme izlenmiş olup 12 (%60) hastada birinci ayda tam rezolüsyon görüldü. İkinci ay kontrolerinde toplamda 18 hastada tam rezolüsyon, üçüncü ay kontolleri devam eden 2 hastada ise lezyon boyutlarında küçülme mevcuttu. Hastaların 2’sinde enjeksiyon sonrasında cilt depigmentasyonu gözlenmiş olup üçüncü ay kontrolleri sonunda depigmentasyon saptanmadı ve gözlenen başka bir komplikasyon olmadı. Sonuç: İzlenen yüksek başarı oranları neticesinde konservatif ve medikal tedaviye yanıtsız şalazyon hastalarında lezyon içine uygulanan triamsinolon asetonid enjeksiyonu, cerrahi tedavi öncesi bir seçenek olarak düşünülebilir.

Anahtar Kelimeler

• Şalazyon
• Triamsinolon asetonid
• cerrahi tedavi

Efficiency of Triamcinolone Acetonide Injection in the Treatment of Chalazion

Öz

Purpose: To evaluate the efficacy and safety of triamcinolone acetonide injection into the lesion in the treatment of chalazion. Materials and Methods: Twenty eyes with medium (3-7 mm) and large sizes (> 7 mm) primary chalazion that did not respond to conservative and medical treatment lasting at least one month were retrospectively analyzed. Lesion sizes and complications were recorded by injecting 0.1-0.2 mL triamcinolone acetonide (40 mg / mL) into the lesions, and the second week before and after the injection, first month, second month, third month after injection. Results: In the second week post-injection, 17 (85%) patients had a decrease in lesion size, and 12 (60%) patients had complete resolution in the first month. In the second month controls, a total of 18 patients had complete resolution, and 2 patients who continued their third month control had a reduction in lesion size. In 2 of the patients, skin hypopigmentation was observed after injection, and depigmentation was not detected at the end of the 3rd month controls and there were no other complications observed. Conclusion: As a result of the high success rates observed, triamcinolone acetonide injection may be considered as a pre-surgical option.

Anahtar Kelimeler

• Chalazion
• Triamcinolone acetonide

Kaynakça

1. 1. Jin KW, Shin YJ, Hyon JY. Effects of chalazia on corneal astigmatism: Large-sized chalazia in middle upper eyelids compress the cornea and induce the corneal astigmatism. BMC Ophthalmol 2017;17(1):36.
2. 2. Dua HS, Nilawar DV. Nonsurgical therapy of chalazion [letter]. Am J Ophthalmol 1982;94:424–5.
3. 3. Garrett GW, Gillespie ME, Mannix BC. Adrenocorticosteroid injection vs. conservative therapy in the treatment of chalazia. Ann Ophthalmol 1988;20:196–8.
4. 4. Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology 1980;87:218–21.
5. 5. Aycinena AR, Achiron A, Paul M, Burgansky-Eliash Z. Incision and Curettage Versus Steroid Injection for the Treatment of Chalazia: A Meta-Analysis. Ophthalmic Plast Reconstr Surg 2016;32(3):220-4.
6. 6. Unal M. Chalazion treatment. Orbit 2008;27(6):397–398.
7. 7. Ben Simon GJ, Rosen N, Rosner M, Spierer A. Intralesional triamcinolone acetonide injection versus incision and curettage for primary chalazia: a prospective, randomized study. Am J Ophthalmol 2011;151(4):714–718.
8. 8. Goawalla A, Lee V. A prospective randomized treatment study comparing three treatment options for chalazia: triamcinolone acetonide injections, incision and curettage and treatment with hot compresses. Clin Exp Ophthalmol 2007;35(8):706–712.

9. 9. Khurana A.K., Ahluwalia B.K., Rajan C. Chalazion Therapy. Intralesional steroids versus incision and curettage. Acta Ophthalmol 1988;66(3):352–354.
10. 10. Thomas EL, Laborde RP. Retinal and choroidal vascular occlusion following intralesional corticosteroid injection of a chalazion. Ophthalmology 1986;93(3):405-7.
11. 11. Ağci A, Palamar M, Eğrilmez S, Sahbazov C, Ozbek SS. Anterior segment ischemia and retinochoroidal vascular occlusion after intralesional steroid injection. Ophthal Plast Reconstr Surg 2008;24(1):55-7.
12. 12. Procope JA, Kidwell ED Jr. Delayed postoperative hemorrhage complicating chalazion surgery. J Natl Med Assoc 1994;86(11):865-6.
13. 13. Cohen BZ, Tripathi RC. Eyelid depigmentation after intralesional injection of a fluorinated corticosteroid for chalazion. Am J Ophthalmol 1979;88(2):269-70.
14. 14. Kim E, Yu S, Jeong B, Lee K, Mun H. The Effects of intralesional steroid injection for chalazion according to the concentrations of triamcinolone acetonide. J Korean Ophthalmol Soc 2013;54(3):396–400.
15. 15. Cosar CB, Rapuano CJ, Cohen EJ, Laibson PR. Chalazion as a cause of decreased vision after LASIK. Cornea 2001;20(8):890-2.
16. 16. Mohan K, Dhir SP, Munjal VP, Jain IS. The use of intralesional steroids in the treatment of chalazion. Ann Ophthalmol 1986;18:158 – 60.